New shot aims to calm stubborn hives triggered by cold or scratching
Symptom relief
Recruiting now
This early-stage study tests a single dose of a new drug called GTX-B001 in healthy volunteers and people with chronic inducible urticaria — a condition where cold or scratching causes painful hives. The main goal is to check safety and side effects. About 72 people will take par…
Phase: PHASE1 • Sponsor: Granular Therapeutics Limited • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC